BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20145264)

  • 1. CXCL12-induced chemotaxis is impaired in T cells from patients with ZAP-70-negative chronic lymphocytic leukemia.
    Borge M; Nannini PR; Galletti JG; Morande PE; Avalos JS; Bezares RF; Giordano M; Gamberale R
    Haematologica; 2010 May; 95(5):768-75. PubMed ID: 20145264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL).
    Richardson SJ; Matthews C; Catherwood MA; Alexander HD; Carey BS; Farrugia J; Gardiner A; Mould S; Oscier D; Copplestone JA; Prentice AG
    Blood; 2006 May; 107(9):3584-92. PubMed ID: 16332969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic lymphocytic leukemia cells receive RAF-dependent survival signals in response to CXCL12 that are sensitive to inhibition by sorafenib.
    Messmer D; Fecteau JF; O'Hayre M; Bharati IS; Handel TM; Kipps TJ
    Blood; 2011 Jan; 117(3):882-9. PubMed ID: 21079155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signaling through ZAP-70 is required for CXCL12-mediated T-cell transendothelial migration.
    Ticchioni M; Charvet C; Noraz N; Lamy L; Steinberg M; Bernard A; Deckert M
    Blood; 2002 May; 99(9):3111-8. PubMed ID: 11964272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells.
    Cutrona G; Colombo M; Matis S; Fabbi M; Spriano M; Callea V; Vigna E; Gentile M; Zupo S; Chiorazzi N; Morabito F; Ferrarini M
    Haematologica; 2008 Mar; 93(3):413-22. PubMed ID: 18287138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients.
    Borge M; Nannini PR; Morande PE; Jancic C; Bistmans A; Bezares RF; Giordano M; Gamberale R
    Cancer Immunol Immunother; 2013 Jan; 62(1):113-24. PubMed ID: 22842611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ZAP-70 enhances migration of malignant B lymphocytes toward CCL21 by inducing CCR7 expression via IgM-ERK1/2 activation.
    Calpe E; Codony C; Baptista MJ; Abrisqueta P; Carpio C; Purroy N; Bosch F; Crespo M
    Blood; 2011 Oct; 118(16):4401-10. PubMed ID: 21865343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45.
    Fernandis AZ; Cherla RP; Ganju RK
    J Biol Chem; 2003 Mar; 278(11):9536-43. PubMed ID: 12519755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
    Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
    Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method.
    Gachard N; Salviat A; Boutet C; Arnoulet C; Durrieu F; Lenormand B; Leprêtre S; Olschwang S; Jardin F; Lafage-Pochitaloff M; Penther D; Sainty D; Reminieras L; Feuillard J; Béné MC;
    Haematologica; 2008 Feb; 93(2):215-23. PubMed ID: 18223290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZAP-70 promotes the infiltration of malignant B-lymphocytes into the bone marrow by enhancing signaling and migration after CXCR4 stimulation.
    Calpe E; Purroy N; Carpio C; Abrisqueta P; Carabia J; Palacio C; Castellví J; Crespo M; Bosch F
    PLoS One; 2013; 8(12):e81221. PubMed ID: 24312539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pitfalls and limitations of ZAP-70 detection in chronic lymphocytic leukemia.
    Vroblova V; Smolej L; Krejsek J
    Hematology; 2012 Sep; 17(5):268-74. PubMed ID: 22971532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the CXCR4 pathway using a novel anti-CXCR4 IgG1 antibody (PF-06747143) in chronic lymphocytic leukemia.
    Kashyap MK; Amaya-Chanaga CI; Kumar D; Simmons B; Huser N; Gu Y; Hallin M; Lindquist K; Yafawi R; Choi MY; Amine AA; Rassenti LZ; Zhang C; Liu SH; Smeal T; Fantin VR; Kipps TJ; Pernasetti F; Castro JE
    J Hematol Oncol; 2017 May; 10(1):112. PubMed ID: 28526063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zeta-chain associated protein 70 and CD38 combined predict the time to first treatment in patients with chronic lymphocytic leukemia.
    Del Giudice I; Morilla A; Osuji N; Matutes E; Morilla R; Burford A; Maravelaki S; Owusu-Ankomah K; Swansbury J; A'Hern R; Brito-Babapulle V; Catovsky D
    Cancer; 2005 Nov; 104(10):2124-32. PubMed ID: 16211545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ZAP-70 expression in 24 patients with B cell chronic lymphocytic leukemia].
    Wu YJ; Li JY; Zhu GR; Song JH; Xiao B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Apr; 14(2):237-40. PubMed ID: 16638188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
    Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZAP-70 expression and proliferative activity in chronic lymphocytic leukemia.
    Šoljić V; Perak RB; Vukojević K; Saraga-Babić M; Bubalo P; Karan D; Todorović J; Batinić D
    Leuk Lymphoma; 2013 Jun; 54(6):1171-6. PubMed ID: 23098292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells.
    Vaisitti T; Aydin S; Rossi D; Cottino F; Bergui L; D'Arena G; Bonello L; Horenstein AL; Brennan P; Pepper C; Gaidano G; Malavasi F; Deaglio S
    Leukemia; 2010 May; 24(5):958-69. PubMed ID: 20220774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia.
    Schroers R; Griesinger F; Trümper L; Haase D; Kulle B; Klein-Hitpass L; Sellmann L; Dührsen U; Dürig J
    Leukemia; 2005 May; 19(5):750-8. PubMed ID: 15759031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZAP-70 expression in B-cell chronic lymphocytic leukemia: evaluation by external (isotypic) or internal (T/NK cells) controls and correlation with IgV(H) mutations.
    Zucchetto A; Bomben R; Bo MD; Nanni P; Bulian P; Rossi FM; Del Principe MI; Santini S; Del Poeta G; Degan M; Gattei V
    Cytometry B Clin Cytom; 2006 Jul; 70(4):284-92. PubMed ID: 16906587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.